ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS

被引：0
|
作者：
Rovida, E. [1 ]
Navari, N. [1 ]
Cannito, S. [2 ]
Dello Sbarba, P. [1 ]
Parola, M. [2 ]
Marra, F. [1 ]
机构：
[1] Univ Florence, Florence, Italy
[2] Univ Turin, Turin, Italy
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
10.1016/S0168-8278(10)60893-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [21] Factors Associated with Survival of Hepatocellular Carcinoma (HCC) Patients at a Safety Net Hospital in Arizona without On-Site Liver Transplant Program
    Turse, Erica
    Aboona, Majd
    Charley, Ericka
    Forlemu, Arnold
    Bowie, Tessa
    Bhattarai, Bikash
    Chuang, Keng-Yu
    Nadir, Abdul
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 1 - 11
  • [22] Cumulative Incidence and Risk Factors of Hepatocellular Carcinoma (HCC) in Patients with END-Stage Liver Disease Secondary to Nonalcoholic Steatohepatitis (NASH)
    Ascha, Mustafa S.
    Hanouneh, Ibrahim
    Lopez, Rocio
    Tamimi, Tarek I. Abu-Rajab
    Albeldawi, Mazel
    Feldstein, Ariel E.
    McCullough, Arthur J.
    Zein, Nizar N.
    GASTROENTEROLOGY, 2009, 136 (05) : A797 - A797
  • [23] Evidence that an extension of Milan criteria to 5-5 criteria does not impact survival nor HCC recurrence after liver transplantation for hepatocellular carcinoma
    Badran, Hanaa M.
    Meyer, Carole
    Adam, Rene
    Plessier, Aurelie
    Durand, Francois
    Boillot, Olivier
    Dumortier, Jerome
    Dharancy, Sebastien
    Hilleret, Marie Noelle
    Decaens, Thomas
    Cherqui, Daniel
    Duvoux, Christophe
    HEPATOLOGY, 2006, 44 (04) : 422A - 422A
  • [24] Detection of Circulating Tumour Cells (CTCs), with Expression of Epithelial and Stem Cell Markers in Treatment Naive, Liver Confined Hepatocellular Carcinoma (HCC)
    Mishra, Manjul
    Negi, Pooja
    Agrawal, Tanvi
    Sehgal, Rashi
    Ramakrishna, Gayatri
    Trehanpati, Nirupma
    Bhatia, Vikram
    Sarin, Shiv Kumar
    HEPATOLOGY, 2018, 68 : 511A - 511A
  • [25] ACTIVATED RAS ONCOGENE P21 EXPRESSION IN HEPATOCELLULAR-CARCINOMA (HCC) AND HBSAG-POSITIVE LIVER-CELLS
    JAGIRDAR, J
    NONOMURA, A
    PATIL, J
    PARONETTO, F
    HEPATOLOGY, 1985, 5 (05) : 1055 - 1055
  • [26] Dysfunctional Natural Killer cells expanded from a liver with Hepatocellular Carcinoma show reduced killing against a unique HCC cell line
    Badeti, Saiaditya
    Yang, Yan
    Yang, Lei
    Luna, Aesis
    Liu, Dongfang
    Liu, Chen
    FASEB JOURNAL, 2020, 34
  • [27] Liver transplant for hepatocellular carcinoma (HCC). Are we missing some factors in the procedure's outcomes? Single center 3-year experience
    Brahmbhatt, Rinjal
    Jha, Lokesh K.
    Rochling, Fedja A.
    Schafer, Daniel F.
    McCashland, Timothy M.
    Gomez-Martin, Diana
    Olivera-Martinez, Marco A.
    HEPATOLOGY, 2014, 60 : 887A - 887A
  • [28] Overexpression of leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5) in a subset of hepatocellular carcinoma (HCC) promotes cancer stemness properties and cell migration of HCC cells
    Tsui, Y. M.
    Sze, K. M. F.
    Tung, E. K. K.
    Lee, T. K. W.
    Ng, I. O. L.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S63 - S63
  • [29] Phase I and pharmacokinetic study of 5-fluorouracil (5-FU) 5-day continuous infusion in hepatocellular carcinoma (HCC) patients with liver cirrhosis (LC).
    Okada, S
    Nakayama, H
    Okusaka, T
    Ishii, H
    Ikeda, M
    Nakasuka, H
    Kosakamoto, H
    Yamamoto, N
    Yoshimori, M
    GASTROENTEROLOGY, 1998, 114 (04) : A1316 - A1316
  • [30] Stereotactic Body Radiation Therapy (SBRT) as a Bridge to Orthotropic Liver Transplant (OLT) for Hepatocellular Carcinoma (HCC): Evaluation of Explant Pathology and the Factors That Predict Outcomes
    Lappinen, E. K.
    Hall, M.
    Thai, N.
    Tom, K.
    Khan, A.
    Yergiyev, A.
    Silverman, J.
    Kirichenko, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S318 - S319
12345